Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Texas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Texas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Texas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Christopher Wright (NPI 1356571087)

Field	Value
Entity Type	Individual
Organization	Christopher Wright
Address	8144 Walnut Hill Ln Ste 800
City	Dallas
State	TX
ZIP	75231
Taxonomy	Rheumatology Physician
NPI Enumerated	July 15, 2009

Payer Source	Total Paid
Medicare	$1.4M
Medicaid	$0

Key Findings

This provider’s billing is effectively single-payer: lifetime Medicare revenue is $1.4M while there is no Medicaid billing on file. The absence of any Medicaid claims indicates this NPI’s Medicare activity represents the vast majority of its public-payer footprint rather than a balanced dual-payer mix.

Revenue is highly concentrated in a small set of biologic drug codes: the top three Medicare codes (J9312, J0129, J1602) account for 61.5% of the provider’s total Medicare revenue. Individually those codes generate $352.8K (J9312, 24.3%), $288.2K (J0129, 19.9%), and $250.8K (J1602, 17.3%) of Medicare revenue, making biologic administration the primary revenue driver.

The CPT/HCPCS mix and volumes point to an infusion-oriented rheumatology practice: high-revenue injectable biologics (J9312, J0129, J1602, J3262, J1745) combined with infusion/chemotherapy administration codes (96413, 96365, 96415) indicate in-office or clinic-based IV/subcutaneous therapy delivery rather than a pure outpatient office visit model. This service-line footprint is consistent with management of chronic inflammatory and autoimmune conditions that require regular biologic dosing.

Competitive standing on the top biologics is mixed: J9312 ranks #49 of 317 providers nationally (84th percentile) and is characterized in the source as typical, unremarkable volume despite being the single largest revenue contributor; J0129 ranks #584 of 1221 (52th percentile) and J1602 ranks #249 of 1041 (76th percentile), both also labeled typical, unremarkable. In short, the provider is a meaningful but not dominant national participant for most high-cost biologic codes, with one stronger placement (J9312) and otherwise modest-to-typical positioning.

Office evaluation-and-management activity is present but not the primary revenue stream: 99214 produced 651 claims and $57.3K (4.0% of Medicare revenue) and ranks #30401 of 479517 providers nationally (94th percentile), a placement described as notably above typical national volume. Higher-than-typical E/M placement for 99214 suggests frequent longitudinal follow-up visits accompanying the infusion/biologic treatment regimen.

Laboratory and monitoring codes appear consistently used alongside drug therapy: 80053 (606 claims, $6.1K, 0.4% of revenue) ranks in the 89th percentile and 86140 (602 claims, $3K, 0.2%) ranks in the 91th percentile, both labeled typical, unremarkable volume. This pattern of routine CMP, CRP, CBC and immunology testing aligns with standard rheumatology monitoring for patients on disease-modifying biologics.

The provider’s NPI has been active for an extended period—enumerated 2009-07-15 (~17 years ago)—indicating an established practice history that aligns with sustained Medicare billing across high-cost biologics and associated services. Longevity supports that the current code mix represents an ongoing operational model rather than a transient billing pattern.

The practice’s heavy reliance on high-cost injectable biologics creates revenue concentration risk: with 61.5% of Medicare revenue coming from the top three drug codes, reimbursement changes, formulary shifts, or utilization changes for these agents could materially affect revenue. Operationally, the combination of drug administration codes and above-typical 99214 volume means clinical throughput and infusion capacity are likely key drivers of financial performance and payer negotiations.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

44 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9312	Injection, rituximab, 10 mg	5,600	$60	$352.8K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	8,480	$30	$288.1K
J1602	Injection, golimumab, 1 mg, for intravenous use	22,800	$10	$250.8K
J3262	Injection, tocilizumab, 1 mg	38,560	$10	$192.8K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	5,940	$30	$154.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	650	$90	$57.3K
J0897	Injection, denosumab, 1 mg	3,060	$20	$55.1K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	230	$110	$24.1K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	150	$130	$19.1K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	240	$50	$12.7K

Showing 1–10 of 44

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 44 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Texas Distribution

Christopher Wright — 0 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Texas

Full comparison — all codes billed, vs. state median

44 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	6	100	9,950	$30	$393.1K
J9312	2	20	3,830	$60	$248.5K
J3262	5	40	31,800	$1	$212K
J1602	5	90	14,850	$10	$184.1K
J1745	11	110	2,660	$30	$90.6K
J0897	48	650	2,580	$20	$79.2K
86480	9	30	60	$60	$61.4K
86235	9	70	270	$20	$44K
96413	29	810	150	$100	$19.7K
99214	371	32,500	110	$80	$17.6K

Showing 1–10 of 44

Related Providers

Other providers that share a Tax Identification Number (TIN) with Christopher Wright, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Janet Schwartzenberg	TX	Rheumatology Physician	$2.6M	$0
Sean Lasalle	WA	Rheumatology Physician	$1.7M	$0
Nicole Davey	TX	Rheumatology Physician	$1.4M	$0
Howard Kenney	ID	Rheumatology Physician	$1.2M	$0
Zoran Kurepa	TX	Rheumatology Physician	$1.2M	$0
Carlos Plata	TX	Rheumatology Physician	$969.4K	$0
Sharad Lakhanpal	TX	Rheumatology Physician	$881.6K	$0
Jeffrey Butler	WA	Specialist	$772.9K	$0
Nam Do	TX	Internal Medicine Physician	$702.5K	$0
Alan Keister	TX	Internal Medicine Physician	$669.5K	$0

Nearby Providers

Other providers in the same ZIP code as Christopher Wright, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Dallas Independent School District	TX	Local Education Agency (LEA)	$0	$22.6M
North Star Home Health Care Inc	TX	Personal Care Attendant	$0	$10.8M
Ophthalmology Surgery Center Of Dallas, LLC	TX	Ambulatory Surgical Clinic/Center	$8.3M	$134.6K
Ashkan Abbey	TX	Ophthalmology Physician	$6.4M	$0
Lori Coors	TX	Ophthalmology Physician	$5.2M	$0
Andrew Mcclellan	TX	Ophthalmology Physician	$4.5M	$0
Timothy Fuller	TX	Ophthalmology Physician	$3.5M	$0
Robert Wang	TX	Ophthalmology Physician	$3.5M	$0
Diana Laura	TX	Ophthalmology Physician	$2.3M	$0
Deborah Chong	TX	Ophthalmology Physician	$2.3M	$0

Christopher Wright — Billing Profile & Reimbursement Data

Sign up for Christopher Wright — Billing Profile & Reimbursement Data policy alerts

Christopher Wright — Billing Profile & Reimbursement Data

Sign up for Christopher Wright — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References